GlassScriptPhysician profile
Patrick Paez Gonzales
NPI 1770504417
$632.30
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $385 · 2020: $158 · 2022: $88.93.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $151.31 | 2019-2020 | |
| Painteq LLC | $88.93 | 2022 | |
| Horizon Therapeutics Plc | $88.37 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $80.59 | 2019 | |
| Merck Sharp & Dohme LLC | $49.99 | 2019 | |
| Gilead Sciences, INC. | $29.53 | 2019 | |
| Novo Nordisk INC | $28.02 | 2019 | |
| Amgen INC. | $27.34 | 2019 | |
| Hikma Pharmaceuticals USA | $17.24 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.59 | 2019 | |
| Glaxosmithkline, LLC. | $15.79 | 2019 | |
| Sanofi Pasteur INC. | $14.54 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $12.23 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.83 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Gonzales listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.